Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $844.62 | 35 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $421.15 | 19 | $0 (2024) |
| Neuronetics, Inc. | $106.33 | 1 | $0 (2024) |
| Medtronic, Inc. | $101.88 | 2 | $0 (2022) |
| Avanir Pharmaceuticals, Inc. | $42.90 | 2 | $0 (2022) |
| Collegium Pharmaceutical, Inc. | $39.76 | 2 | $0 (2023) |
| DePuy Synthes Sales Inc. | $24.86 | 2 | $0 (2024) |
| Abbott Laboratories | $24.64 | 1 | $0 (2021) |
| PFIZER INC. | $23.11 | 2 | $0 (2019) |
| Ferring Pharmaceuticals Inc. | $17.14 | 1 | $0 (2023) |
| Amgen Inc. | $15.54 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $296.37 | 10 | ABBVIE INC. ($176.12) |
| 2023 | $271.59 | 12 | ABBVIE INC. ($231.25) |
| 2022 | $173.15 | 6 | Medtronic, Inc. ($101.88) |
| 2021 | $41.20 | 2 | Abbott Laboratories ($24.64) |
| 2019 | $26.92 | 2 | Amgen Inc. ($15.54) |
| 2018 | $35.39 | 3 | Orthogenrx Inc. ($12.72) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/15/2024 | DePuy Synthes Sales Inc. | MONOVISC (Device), ORTHOVISC | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Sports Early Intervention | ||||||
| 10/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/11/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/24/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: NEUROSCIENCE | ||||||
| 07/01/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: NEUROSCIENCE | ||||||
| 06/26/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $106.33 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 05/31/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $27.80 | General |
| Category: NEUROSCIENCE | ||||||
| 05/22/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/10/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.97 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/20/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $5.40 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.70 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/23/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: NEUROSCIENCE | ||||||
| 08/03/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/21/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $24.28 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 05/03/2023 | Ferring Pharmaceuticals Inc. | EUFLEXXA (Device) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: ORTHOPEDICS | ||||||
| 04/19/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 03/09/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: NEUROSCIENCE | ||||||
| 02/22/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 01/24/2023 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $23.20 | General |
| Category: Opioid Analgesic | ||||||
| 01/11/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $29.12 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/29/2022 | Medtronic, Inc. | ACCURIAN (Device) | Food and Beverage | In-kind items and services | $82.22 | General |
| Category: Neuro Pain (includes Interventional) | ||||||
| 09/22/2022 | Boston Scientific Corporation | General - Pain Management (Device) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: General - Pain Management_NMD | ||||||
| 05/24/2022 | Avanir Pharmaceuticals, Inc. | Nuedexta (Drug) | Food and Beverage | In-kind items and services | $26.69 | General |
| Category: pseudobulbar affect (PBA) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 25 | 1,505 | 6,345 | $380,240 | $143,868 |
| 2022 | 24 | 1,047 | 3,044 | $229,805 | $95,345 |
| 2021 | 26 | 1,215 | 4,496 | $297,000 | $130,060 |
| 2020 | 27 | 1,123 | 2,495 | $222,345 | $99,344 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 115 | 246 | $43,050 | $23,277 | 54.1% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 80 | 106 | $51,940 | $21,560 | 41.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 91 | 108 | $44,950 | $16,029 | 35.7% |
| 20611 | Aspiration and/or injection of fluid large joint using ultrasound guidance | Office | 2023 | 106 | 165 | $26,825 | $13,355 | 49.8% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 35 | 65 | $24,750 | $9,718 | 39.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 61 | 61 | $14,030 | $7,324 | 52.2% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 25 | 29 | $13,485 | $5,822 | 43.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 74 | 86 | $9,030 | $5,582 | 61.8% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 50 | 69 | $14,145 | $5,248 | 37.1% |
| J7318 | Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | Office | 2023 | 12 | 900 | $23,580 | $4,735 | 20.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 58 | $7,250 | $4,000 | 55.2% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 70 | 86 | $24,510 | $3,979 | 16.2% |
| 97811 | Acupuncture, each additional 15 minutes | Office | 2023 | 41 | 158 | $10,270 | $3,734 | 36.4% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 24 | 45 | $7,875 | $3,262 | 41.4% |
| 77002 | Fluoroscopic guidance for needle placement | Office | 2023 | 25 | 28 | $6,580 | $2,571 | 39.1% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 50 | 60 | $6,300 | $2,472 | 39.2% |
| 97810 | Acupuncture, initial 15 minutes | Office | 2023 | 41 | 79 | $7,505 | $2,455 | 32.7% |
| 95910 | Nerve conduction, 7-8 studies | Office | 2023 | 14 | 14 | $4,690 | $1,912 | 40.8% |
| 95909 | Nerve conduction, 5-6 studies | Office | 2023 | 19 | 19 | $4,940 | $1,805 | 36.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 24 | 27 | $3,105 | $1,369 | 44.1% |
| 20526 | Injection of carpal tunnel | Office | 2023 | 17 | 21 | $2,625 | $1,262 | 48.1% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 248 | 1,342 | $13,420 | $1,111 | 8.3% |
| 95908 | Nerve conduction, 3-4 studies | Office | 2023 | 11 | 12 | $2,580 | $998.14 | 38.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 118 | 2,400 | $12,000 | $233.52 | 1.9% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2023 | 111 | 161 | $805.00 | $53.80 | 6.7% |
About Dr. Michael Ellenberg, MD
Dr. Michael Ellenberg, MD is a Electrodiagnostic Medicine healthcare provider based in Novi, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1164556692.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Ellenberg, MD has received a total of $844.62 in payments from pharmaceutical and medical device companies, with $296.37 received in 2024. These payments were reported across 35 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($844.62).
As a Medicare-enrolled provider, Ellenberg has provided services to 4,890 Medicare beneficiaries, totaling 16,380 services with total Medicare billing of $468,618. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Electrodiagnostic Medicine
- Other Specialties Sports Medicine, Interventional Pain Medicine
- Location Novi, MI
- Active Since 03/15/2007
- Last Updated 03/14/2025
- Taxonomy Code 204R00000X
- Entity Type Individual
- NPI Number 1164556692
Products in Payments
- BOTOX (Biological) $379.57
- NEUROSTAR TMS THERAPY SYSTEM (Device) $106.33
- ACCURIAN (Device) $82.22
- Nuedexta (Drug) $42.90
- UBRELVY (Drug) $27.80
- MONOVISC (Device) $24.86
- Proclaim IPG (Device) $24.64
- Belbuca (Drug) $23.20
- LYRICA (Drug) $23.11
- INTELLIS ADAPTIVESTIM (Device) $19.66
- EUFLEXXA (Device) $17.14
- XTAMPZA (Drug) $16.56
- Aimovig (Biological) $15.54
- General - Pain Management (Device) $14.59
- QULIPTA (Drug) $13.78
- GenVisc 850 (Device) $12.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.